SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T111. A total of 16 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33 | -32.7% | 465,717 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $49 | +172.2% | 465,717 | -6.5% | 0.00% | +100.0% |
| Q1 2023 | $18 | -21.7% | 498,109 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $23 | -99.9% | 498,109 | -24.8% | 0.00% | 0.0% |
| Q3 2022 | $41,000 | -73.7% | 662,699 | -19.6% | 0.00% | -75.0% |
| Q2 2022 | $156,000 | -60.7% | 823,999 | -0.1% | 0.00% | -60.0% |
| Q1 2022 | $397,000 | -73.7% | 824,999 | -2.0% | 0.01% | -74.4% |
| Q4 2021 | $1,507,000 | – | 841,795 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LMR Partners LLP | 358,349 | $520,000 | 0.01% |
| Shaolin Capital Management LLC | 823,999 | $156,000 | 0.00% |
| Yakira Capital Management, Inc. | 108,485 | $17,000 | 0.00% |
| Radcliffe Capital Management, L.P. | 55,692 | $81,000 | 0.00% |
| EQUITEC PROPRIETARY MARKETS, LLC | 45,000 | $7,000 | 0.00% |
| MARSHALL WACE, LLP | 285,000 | $413,000 | 0.00% |
| MORGAN STANLEY | 148,939 | $22,000 | 0.00% |
| Walleye Trading LLC | 15,505 | $2,000 | 0.00% |
| Citadel Advisors | 18,711 | $3,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,944 | $2,000 | 0.00% |